Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi Center, Non-randomized, Open, Phase 3 Study to Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI Diagnosis in Prostate Cancer Risk Groups

NCT05004285 is registered in ClinicalTrials.gov with FutureChem as lead sponsor.

NCT NCT05004285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05004285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi Center, Non-randomized, Open, Phase 3 Study to Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI Diagnosis in Prostate Cancer Risk Groups
Lead sponsor
FutureChem
Phase
Phase 3
Overall status
Active, not recruiting
Start date
April 28, 2021
Completion date
June 1, 2025
Enrollment
398 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

high risk prostate carcinoma